Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 4 of the last 4 fiscal years.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Figures corrected NBB
Corrected annual account filed for 2024.
-
Busy address KBO
57 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
PHORMIO from Sint-Joost-ten-Node, company number BE0873430659, closed financial year 2025 with a result of € -334,547 after tax. For that financial year PHORMIO recorded revenue of € 780,000 and equity of € -7.3 million. Compared with financial year 2024, the result moved from € -640,262 to € -334,547. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on April 21, 2026.
€ -7.3 million
▼ € 334,547 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -334,547
▲ 48 % less loss than in 2024
Profit after tax over the fiscal year.
€ 102,536
▲ 6% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -11.4 million.
People and assets in 2025
€ 3,015
▼ 71% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 15.3 million
€ 15,500 is repaid this year. At this pace the long-term loan is gone in ≈ 985 years.
€ 6,654
▲ 72% vs 2024
Supplier invoices still open on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | - | - | - | € 780,000 | |
| Gross margin | € -58,256 | € 549,463 | € 653,408 | € 686,794 | ▲ 5% |
| Profit after taxes | € -797,244 | € -865,171 | € -640,262 | € -334,547 | ▲ € 305,715 |
| Equity | € -5,441,310 | € -6,306,481 | € -6,946,743 | € -7,281,290 | ▼ € 334,547 |
| Total debts | € 14,228,754 | € 14,831,814 | € 15,284,234 | € 15,346,624 | |
| Cash | € 120 | € 758 | € 96,790 | € 102,536 | ▲ 6% |
| Land & buildings | € 8,756,022 | € 8,485,315 | € 8,214,614 | € 7,945,122 | ▼ 3% |
| Retained profit | € -9,564,270 | € -10,429,441 | € -11,069,703 | € -11,404,250 | ▼ € 334,547 |
| Bank debt | € 0 | € 9,111,956 | € 15,271,368 | € 15,271,368 | |
| Balance sheet total | € 8,787,445 | € 8,525,333 | € 8,337,491 | € 8,065,334 | ▼ 3% |
Key figures of PHORMIO, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHORMIO?
What happened at PHORMIO in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Thierry De Wever stepped down as director. NBB
- Jan Bekaert stepped down as director. NBB
- KPMG Bedrijfsrevisoren BV stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 334,547. Source: NBB ↗
- Thierry De Wever became a director. NBB
- Jan Bekaert became a director. NBB
- KPMG Bedrijfsrevisoren BV became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 797,244 loss in 2022 to € 334,547 loss in 2025.
A new publication or filing at PHORMIO? We notify you, reason included.
Follow PHORMIODatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of DEUS comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
PHORMIOThe shares are held by Belfius Banque (100%) and DEUS (100%).
Directors
According to the 2025 annual accounts
Thierry De Wever
Director
since 2024 · until 2030
Auditor · represented by Onclin Bastien (A02677)
Also active at: Holding Communal - Gemeentelijke Holding - Gemeindliche Holding, CREFIUS, De Oever, H.E. MANAGEMENT (BELGIE), ASCOM (BELGIUM), Makita Europe, FIXXER, MCA Horeca +3 more
since 2024 · until 2027
Jan Bekaert
Director
since 2024 · until 2030
Shareholders
100%
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Karel Rogierplein 11
1210 Sint-Joost-ten-Node
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 57 companies are registered at this address.
All companies at this address →BELFIUS BANK same network
CREFIUS same network
€ 36.9 million revenue · 2025
BELFIUS VERSICHERUNGEN
CAPLINE
€ 37,500 revenue · 2025
BELFIUS FIDUCIAIRE
€ 167,847 gross margin · 2025
+52 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0873.430.659
- VAT number
- BE 0873.430.659
- Registered office
- Karel Rogierplein 11, 1210 Sint-Joost-ten-Node
- Names & denominations
- PHORMIO
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 25 April 2005
- Peppol
- Active · Active since 27 Mar 2026
- Activities · NACE
Bemiddeling in verband met exploitatie van en handel in onroerend goed